NCT06067308

Brief Summary

The investigators' aim in this study is to assess the sensitivity and accuracy of YEARS algorithm in the diagnosis of PE.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 16, 2022

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 16, 2023

Completed
28 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 13, 2023

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 15, 2023

Completed
19 days until next milestone

First Posted

Study publicly available on registry

October 4, 2023

Completed
Last Updated

October 4, 2023

Status Verified

September 1, 2023

Enrollment Period

7 months

First QC Date

September 15, 2023

Last Update Submit

September 28, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • YEARS score vs CTPA in diagnosis of PE

    In patients with no YEARS items and a D-dimer concentration less than 1000 ng/mL, pulmonary embolism was considered excluded and further testing was withheld. In patients with one or more YEARS items and a D-dimer concentration less than 500 ng/mL, pulmonary embolism was also considered excluded and further testing was withheld. All other patients i.e., either with no YEARS item and a D-dimer concentration of 1000 ng/mL or more, or with one or more items and a concentration of 500 ng/mL or more were referred for CTPA to show or exclude the diagnosis of pulmonary embolism.

    One year

Study Arms (1)

to assess the sensitivity and accuracy of YEARS score in the diagnosis of PE.

EXPERIMENTAL

50 patients with suspected PE were evaluated in Chest Department at faculty of medicine, Kasr Al-Ainy Hospital. At the beginning, clinical evaluation using YEARS score was done; subsequently for definitive diagnosis, computed tomography pulmonary angiography was performed in all cases as a reference method.

Diagnostic Test: Performance of CTPA

Interventions

Performance of CTPADIAGNOSTIC_TEST

Exposure to CT scan and injection of IV contrast

to assess the sensitivity and accuracy of YEARS score in the diagnosis of PE.

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Any patient more than 18 years old presenting to the emergency room with symptoms of clinically suspected pulmonary embolism such as:
  • Sudden onset of dyspnea, sudden deterioration of existing dyspnea, sudden onset of pleuritic chest pain without another apparent cause.
  • Any other symptoms like hemoptysis, syncope or unilateral leg pain.

You may not qualify if:

  • Pregnancy
  • Allergy to intra-venous contrast agents
  • Renal insufficiency (creatinine clearance \< 30 mL/min).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of medicine

Cairo, Giza Governorate, 222, Egypt

Location

Related Publications (1)

  • Almeida NA, de Sousa JT, Bachion MM, Silveira Nde A. [The use of respiration and relaxation techniques for pain and anxiety relief in the parturition process]. Rev Lat Am Enfermagem. 2005 Jan-Feb;13(1):52-8. doi: 10.1590/s0104-11692005000100009. Epub 2005 Mar 3. Portuguese.

    PMID: 15761580BACKGROUND

MeSH Terms

Conditions

Pulmonary Embolism

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesEmbolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

September 15, 2023

First Posted

October 4, 2023

Study Start

October 16, 2022

Primary Completion

May 16, 2023

Study Completion

June 13, 2023

Last Updated

October 4, 2023

Record last verified: 2023-09

Locations